Seeking Alpha
 

Exelixis, Inc. (EXEL)

- NASDAQ
  • LaboMedic | Send Message 26 Feb

    $EXEL Cowen Reiterates Market Perform Rating On Exelixis, Inc. Following 4Q14 Results http://bit.ly/1FxQiI3
    Reply
      • fda_tracker | Send Message 19 Feb

        $EXEL New PDUFA Date 2015-08-11 EXELIXIS, INC. Calendar:http://bit.ly/1AvmIS6 Link:http://bit.ly/1JrySmQ
        Reply
          • Daniel Ward | Send Message 18 Feb

            Even With Recent Exelixis Price Action, Outlook Remains Unchanged $EXEL http://seekingalpha.com/a/1qmpm
            Reply
              • Thomas Chin | Send Message 17 Feb

                Exelixis: Expected METEOR Trial Success Changes Everything $EXEL http://seekingalpha.com/a/1qn2e
                Reply
                  • Christopher F. Davis | Send Message 7 Jan

                    Update: My Take On Exelixis' New Agreement With Sobi To Provide COMETRIQ In Europe $EXEL http://seekingalpha.com/a/1o3n9
                    Reply
                      • Christopher F. Davis | Send Message 16 Dec 2014

                        Exelixis' Partners File New Drug Application For Cobemetinib - Welcome News But Little Impact $EXEL http://seekingalpha.com/a/1n42z
                        Reply
                          • Daniel Ward | Send Message 3 Dec 2014

                            Exelixis' COMET-2 Failure And A Discussion Of Potential Future Cash Flow $EXEL http://seekingalpha.com/a/1meyj
                            Reply
                              • Christopher F. Davis | Send Message 1 Dec 2014

                                Update: Exelixis Announces Final COMET-2 Data- What Can Shareholders Do? $EXEL http://seekingalpha.com/a/1mc0p
                                Reply
                                  • Mike1968 | Send Message 30 Nov 2014

                                    Any thoughts on $exel .10 drop on Friday? I didn't notice any negative news regarding it.
                                    Reply
                                      • Daniel Ward | Send Message 18 Nov 2014

                                        Exelixis (EXEL): Why This Company Could Become The Next Dendreon $EXEL http://seekingalpha.com/a/1lmht
                                        Reply
                                          Visit Seeking Alpha's
                                          EXEL vs. ETF Alternatives
                                          Company Description
                                          Exelixis Inc is a biotechnology company that develops small molecule therapies for the treatment of cancer.
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States